Home › Funds › Cormorant Asset Management, LP › CLYM
Cormorant Asset Management, LP position in CLYM
CLIMB BIO INC · Health Care
Cormorant Asset Management, LP reported holding 2,106,000 shares of CLYM (CLIMB BIO INC) in its Q2 2026 13F filing — a position valued at US$27.5M, representing 1.41% of its reported portfolio and ranking #21 among its reported holdings. Cormorant Asset Management, LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Cormorant Asset Management, LP's CLYM position evolved
Cormorant Asset Management, LP first disclosed a stake in CLYM in Q2 2026 at 2,106,000 shares (US$27.5M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 2.11M | $27.46M | New |
About CLYM and 13F data
CLYM (CLIMB BIO INC) is a Health Care company. 75 other funds we track also report a position in CLYM — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$147.4M), BRAIDWELL LP (US$36.5M), Redmile Group, LLC (US$16.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CLYM
- RA CAPITAL MANAGEMENT, L.P. 11.30M sh · $147.36M · Q2 2026
- BRAIDWELL LP 2.80M sh · $36.48M · Q2 2026
- Redmile Group, LLC 1.23M sh · $15.99M · Q2 2026
- GREAT POINT PARTNERS LLC 1.00M sh · $13.04M · Q2 2026
- Affinity Asset Advisors, LLC 972.00K sh · $12.67M · Q2 2026
- ADAR1 Capital Management, LLC 822.65K sh · $10.73M · Q2 2026
- STEMPOINT CAPITAL LP 742.75K sh · $9.69M · Q2 2026
- Parkman Healthcare Partners LLC 563.48K sh · $7.35M · Q2 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 521.08K sh · $6.79M · Q2 2026
- SPHERA FUNDS MANAGEMENT LTD. 483.75K sh · $6.31M · Q2 2026
- NAN FUNG TRINITY (HK) Ltd 360.65K sh · $4.70M · Q2 2026
- Ally Bridge Group (NY) LLC 249.17K sh · $3.25M · Q2 2026
More on Cormorant Asset Management, LP
FAQ
How long has Cormorant Asset Management, LP held CLYM?
Cormorant Asset Management, LP has disclosed CLYM holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Cormorant Asset Management, LP's current position in CLYM?
As of Q2 2026, Cormorant Asset Management, LP holds 2.11M shares of CLYM (CLIMB BIO INC), valued at $27.46M, representing 1.41% of its reported portfolio and ranking #21.
Has Cormorant Asset Management, LP been buying or selling CLYM?
In the latest 13F filing (Q2 2026), Cormorant Asset Management, LP newly opened its position in CLYM.
Which other funds hold CLYM?
Other major institutional holders of CLYM include RA CAPITAL MANAGEMENT, L.P., BRAIDWELL LP, Redmile Group, LLC, among 75 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.